Correction: Scalable synthesis and structural characterization of reversible KLK6 inhibitors
Andreas Baumann1, Daniel Isak1, Jasmin Lohbeck1
1Cancer Drug Development Group, German Cancer Research Center (DKFZ) Im Neuenheimer Feld 280 69120 Heidelberg Germany aubry.miller@dkfz.de.
RSC Advances
|November 2, 2022
Abstract:
[This corrects the article DOI: 10.1039/D2RA04670A.].


